Viridian Therapeutics Europe Limited

Active07543968 Private limited company
Incorporated
25 February 2011 (15 years)
Previously known as
Miragen Therapeutics Europe Limited (until 18 February 2021)
Newincco 1092 Limited (until 17 May 2011)
Industry
Research and experimental development on biotechnology (72110)
Directors
Jennifer Dianne Tousignant
Seth Thomas Harmon
Thomas William Beetham
Owned by
Viridian Therapeutics, Inc.
Accounts type
Dormant
Region
Greater London
Address
Cannon Place
78 Cannon Street
London
EC4N 6AF

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
11 March 2027
Last conf. stmt
25 February 2026

Officers 3 active

Officer details are public data from the Companies House register.

Tousignant, Jennifer Dianne
Director · Appointed 26 November 2024
American
Born December 1971 (54)
Harmon, Seth Thomas
Director · Appointed 26 November 2024
American
Born June 1979 (47)
Beetham, Thomas William
Director · Appointed 1 November 2023
American
Born September 1969 (57)
Officer history (8 former)
26 November 2024
Appointed Tousignant, Jennifer Dianne as Director
26 November 2024
Appointed Harmon, Seth Thomas as Director
12 November 2024
Appointed Harmon, Seth as Director
1 April 2024
Resigned Olswang Cosec Limited as Corporate Secretary
1 November 2023
Appointed Beetham, Thomas William as Director
1 November 2023
Resigned Harmon, Seth as Director
12 September 2023
Resigned Humer, Kristian as Director
11 April 2022
Resigned Leverone, Jason Alan as Director
11 April 2022
Appointed Humer, Kristian as Director
5 October 2020
Appointed Leverone, Jason Alan as Director
4 October 2020
Resigned Marshall, William Stuart as Director
26 May 2011
Appointed Marshall, William Stuart as Director
26 May 2011
Resigned Olswang Directors 2 Limited as Corporate Director
26 May 2011
Resigned Olswang Directors 1 Limited as Corporate Director
26 May 2011
Resigned Mackie, Christopher Alan as Director
25 February 2011
Appointed Olswang Directors 2 Limited as Corporate Director
25 February 2011
Appointed Olswang Directors 1 Limited as Corporate Director
25 February 2011
Appointed Mackie, Christopher Alan as Director
25 February 2011
Appointed Olswang Cosec Limited as Corporate Secretary

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Viridian Therapeutics, Inc.
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Corporate
Reg. no. 4910486

Financials

Net Assets
£20
Debt Ratio
0%

Trend

Net Assets
£0 £5 £10 £15 £20 2020 2021 2022 2023 2024 2025 £1 £1 £1 £20 £20 £20
Balance sheet detail
202520242023202220212020
Fixed Assets£0
Current Assets£20£20£20
Cash£1£1£1
Net Current Assets£20£20£20
Net Assets£20£20£20£1£1£1
Shareholder Funds£20£20£20£1£1£1

Filings 63

DateDescriptionMade Up ToPagesPDF
17 September 2026Accounts for a dormant company31 December 2025
10 March 2026Director's details changed
10 March 2026Director's details changed
10 March 2026Confirmation statement with no updates25 February 2026
9 March 2026Previous accounting period shortened
Show all 63 filings

Some other companies at this address

Other companies in this industry

By trade and location

New companies in London →

Explore the largest companies

Largest companies in London, UK →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?